Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice

Jacob Cobb,Jeffrey Rawson,Nelson Gonzalez,Mahmoud Singer,Fouad Kandeel,Mohamed I. Husseiny

DOI: https://doi.org/10.3390/vaccines12030276

2024-03-07

Vaccines

Abstract:A combination therapy of preproinsulin (PPI) and immunomodulators (TGFβ+IL10) orally delivered via genetically modified Salmonella and anti-CD3 promoted glucose balance in in NOD mice with recent onset diabetes. The Salmonella bacteria were modified to express the diabetes-associated antigen PPI controlled by a bacterial promoter in conjunction with over-expressed immunomodulating molecules. The possible mechanisms of action of this vaccine to limit autoimmune diabetes remained undefined. In mice, the vaccine prevented and reversed ongoing diabetes. The vaccine-mediated beneficial effects were associated with increased numbers of antigen-specific CD4+CD25+Foxp3+ Tregs, CD4+CD49b+LAG3+ Tr1-cells, and tolerogenic dendritic-cells (tol-DCs) in the spleens and lymphatic organs of treated mice. Despite this, the immune response to Salmonella infection was not altered. Furthermore, the vaccine effects were associated with a reduction in islet-infiltrating lymphocytes and an increase in the islet beta-cell mass. This was associated with increased serum levels of the tolerogenic cytokines (IL10, IL2, and IL13) and chemokine ligand 2 (CCL2) and decreased levels of inflammatory cytokines (IFNγ, GM-CSF, IL6, IL12, and TNFα) and chemokines (CXCL1, CXCL2, and CXCL5). Overall, the data suggest that the Salmonella-based vaccine modulates the immune response, reduces inflammation, and promotes tolerance specifically to an antigen involved in autoimmune diabetes.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The paper primarily explores the mechanism of action of an oral Salmonella-based vaccine in the prevention and reversal of Type 1 Diabetes (T1D). Specifically, the research team designed an oral, genetically modified Salmonella vaccine that can express antigens related to Type 1 Diabetes—preproinsulin (PPI), as well as immunoregulatory molecules transforming growth factor β (TGF β) and interleukin 10 (IL-10). When used in combination with anti-CD3 monoclonal antibodies, this vaccine can promote glycemic balance in newly diabetic non-obese diabetic (NOD) mouse models.

Key findings of the paper include:
1. **The vaccine reversed diabetes**: 59% of NOD mice with newly onset hyperglycemia returned to normal blood glucose levels within 3 months after receiving the Salmonella vaccine treatment.
2. **Increased regulatory cytokines**: Higher levels of regulatory cytokines (such as IL-10, IL-2, IL-13, and CCL2) were observed in the vaccine-treated mice compared to untreated diabetic mice, which help alleviate inflammatory responses.
3. **Reduced pro-inflammatory cytokines**: The levels of pro-inflammatory cytokines (such as IFN γ, GM-CSF, IL-6, IL-12, and TNF α) were significantly reduced in the vaccine-treated group of mice.
4. **Induced regulatory T cells (Tregs)**: More regulatory T cells (Tregs) were detected in the spleen, mesenteric lymph nodes (MLNs), Peyer's patches (PPs), and pancreatic lymph nodes (PLNs) of the vaccine-treated mice.
5. **Functional Tregs**: In vitro experiments showed that Tregs from the vaccine-treated mice could inhibit the proliferation and activation of other T cells (Tresp) and release more IL-10 and less IFN γ in the culture medium.
6. **Antigen-specific suppressive Tregs**: Through specific antigen stimulation experiments (such as using insulin peptide B9-23), researchers found that the vaccine-treated mice could produce antigen-specific suppressive Tregs, indicating that the vaccine can induce antigen-specific immune tolerance.

In summary, this study reveals that the Salmonella-based vaccine regulates the immune system through multiple mechanisms to achieve effective treatment of Type 1 Diabetes. These mechanisms include increasing the levels of regulatory cytokines, reducing inflammatory responses, and inducing the production of functional regulatory T cells.